Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells
Online Publication Date2016-02-05
Print Publication Date2016-08
Permanent link to this recordhttp://hdl.handle.net/10754/621435
MetadataShow full item record
AbstractThe tumour protein D52 isoform 1 (PC-1), a member of the tumour protein D52 (TPD52) protein family, is androgen-regulated and prostate-specific expressed. Previous studies confirmed that PC-1 contributes to malignant progression in prostate cancer with an important role in castration-resistant stage. In the present work, we identified its impact in mechanisms leading to neuroendocrine (NE) transdifferentiation. We established for long-term PC-1 overexpression an inducible expression system derived from the prostate carcinoma cell line LNCaP. We observed that PC-1 overexpression itself initiates characteristics of neuroendocrine cells, but the effect was much more pronounced in the presence of the cytokine interleukin-6 (IL-6). Moreover, to our knowledge, this is the first report that treatment with IL-6 leads to a significant upregulation of PC-1 in LNCaP cells. Other TPD52 isoforms were not affected. Proceeding from this result, we conclude that PC-1 overexpression enhances the IL-6-mediated differentiation of LNCaP cells into a NE-like phenotype, noticeable by morphological changes and increased expression of typical NE markers, like chromogranin A, synaptophysin or beta-3 tubulin. Immunofluorescent staining of IL-6-treated PC-1-overexpressing LNCaP cells indicates a considerable PC-1 accumulation at the end of the long-branched neuron-like cell processes, which are typically formed by NE cells. Additionally, the experimentally initiated NE transdifferentiation correlates with the androgen receptor status, which was upregulated additively. In summary, our data provide evidence for an involvement of PC-1 in NE transdifferentiation, frequently associated with castration resistance, which is a major therapeutic challenge in the treatment of advanced prostate cancer.
CitationMoritz T, Venz S, Junker H, Kreuz S, Walther R, et al. (2016) Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells. Tumor Biology 37: 10435–10446. Available: http://dx.doi.org/10.1007/s13277-016-4925-1.
- Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
- Authors: Alberti C
- Issue date: 2010 Nov-Dec
- Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.
- Authors: Zelivianski S, Verni M, Moore C, Kondrikov D, Taylor R, Lin MF
- Issue date: 2001 May 28
- Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
- Authors: Yuan TC, Veeramani S, Lin MF
- Issue date: 2007 Sep
- [The influence of neuroendocrine differentiation on the growth and androgen receptor expression of prostate carcinoma cells].
- Authors: Song Y, Wu G, Xin DQ, Na YQ
- Issue date: 2004 Dec 7
- Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
- Authors: Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik L
- Issue date: 2008 Jan 17